Subcutaneous Mastectomy

Subscribe to Selected New Research on Subcutaneous Mastectomy

188 relevant articles (1 outcomes, 6 trials/studies) found for this Therapy

Description: Excision of breast tissue with preservation of overlying skin, nipple, and areola so that breast form may be reconstructed.

Also Known As:

Mastectomy, Subcutaneous; Mastectomies, Subcutaneous; Subcutaneous Mastectomies

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 5

Mastectomy: 4357

Subcutaneous Mastectomy: 188

Experts

1.	Benediktsson, K P: 1 article (02/2008)
2.	Perbeck, L: 1 article (02/2008)
3.	Tyler, M: 1 article (01/2008)
4.	Lamyman, Mj: 1 article (01/2008)
5.	Kelemen, Pond R: 1 article (01/2008)
6.	Ashikari, Roy H: 1 article (01/2008)
7.	Athanassopoulos, A: 1 article (01/2008)
8.	Salzberg, C Andrew: 1 article (01/2008)
9.	Seth, R: 1 article (01/2008)
10.	Lamyman, M J: 1 article (01/2008)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 04/01/1984 - "Breast cancer developed in only 6 patients after subcutaneous mastectomy, an incidence of 0.5%, indicating that subcutaneous mastectomy is effective in preventing breast cancer. " 02/01/2008 - "Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients." 08/01/2008 - "As opposed to more radical ablative techniques, we favour subcutaneous mastectomy as a prophylactic means in women at high risk for breast cancer. " 03/01/2008 - "Endoscopy-assisted subcutaneous mastectomy and immediate breast reconstruction for breast cancer: advantage of the posterior approach." 01/01/2008 - "Subcutaneous mastectomy and immediate reconstruction for prevention of breast cancer for high-risk patients." Order ALL the reference details at left...
2.	Carcinoma (Carcinomatosis) 07/01/1993 - "There was no difference in the prognosis using the case-control comparison method between 34 patients with ipsilateral invasive carcinoma who underwent a subcutaneous mastectomy in this study group and 34 patients who underwent a radical or modified radical mastectomy in the control group. " 01/01/1986 - "(This study suggests that subcutaneous mastectomy in high-risk individuals may not have appropriate prophylaxis against the development of carcinoma of the breast.)" 11/01/1978 - "Histopathologic study of subcutaneous mastectomy specimens from patients with carcinoma of the contralateral breast." 07/15/2002 - "Women with a family history of breast carcinoma were much more likely to have a total mastectomy (89%) than a subcutaneous mastectomy (11%). " 08/01/1998 - "We report a case of breast carcinoma 6 years after a prophylactic subcutaneous mastectomy. " Order ALL the reference details at left...
3.	Gynecomastia 06/01/2009 - "The aim of this study is to introduce the endoscopic subcutaneous mastectomy without skin excision as the standard surgical technique for grade IIB and III gynecomastia. " 06/01/2009 - "Endoscopic subcutaneous mastectomy was performed successfully in 125 breasts of 65 patients with Simon's grade IIB and III gynecomastia. " 06/01/2009 - "Endoscopic subcutaneous mastectomy for the treatment of gynecomastia: a report of 65 cases." 08/01/2005 - "Here we present the case of a 16-year-old adolescent boy who presented with pubertal gynecomastia that was treated with bilateral subcutaneous mastectomies. " 07/01/2004 - "Our preferred approach to high-grade gynecomastia has been the single-stage subcutaneous mastectomy and circumareolar concentric skin reduction with deepithelialization. " Order ALL the reference details at left...
4.	Noninfiltrating Intraductal Carcinoma (DCIS) 01/01/2002 - "When malignant MLL is histologically of low grade, excisional biopsy is sufficient for a single MLL with intraductal carcinoma, while it may be necessary to perform a subcutaneous mastectomy for multiple lesions." 06/15/2001 - "METHODS: An entire breast resected by subcutaneous mastectomy from a 69-year-old woman with ductal carcinoma in situ (DCIS) was examined in submacroscopic sections by stereomicroscopic and histologic techniques. " 02/10/1998 - "Subcutaneous mastectomy should not be used to treat DCIS. " 10/01/1991 - "Sixteen per cent of the patients with DCIS were treated by a breast-conserving operation (BCO), the remaining patients by mastectomy (ME) (52%) or subcutaneous mastectomy (SCM) (33%) with immediate reconstruction. " 10/01/2001 - "METHODS: One hundred and seven patients with primary operable invasive breast carcinoma and associated DCIS treated by simple or subcutaneous mastectomy or wide local excision with radiotherapy were assessed. " Order ALL the reference details at left...
5.	Ductal Carcinoma 11/01/1980 - "Among 6 patients with small intra-ductal carcinomas of the breast two had local recurrences of cancer following unilateral subcutaneous mastectomy. " 07/01/1979 - "The subcutaneous mastectomy with implantation of prothesis is performed today in cases of fibrocystic diseases with atypical epithelial proliferations, in cases with recurrend fibrocystic disease, with non-invasive ductal carcinoma and lobular carcinoma in situ. " 01/01/1981 - "The methods of treatment preferred by the Authors, according to the different types of pathological changes, are the following: a) through follow-up or, alternatively, subcutaneous mastectomy when a "lobular carcinoma in situ"; b) subcutaneous mastectomy and axillary emptying when the diagnosis is found in "intraductal carcinoma"; c) mastectomy, performed according to Patey's technique, or removal of all the involved breast quadrant, axillary emptying and radiotherapy of the residual glandular parenchyma in case of ductal carcinoma or invasive lobular carcinoma less than 0.5 cm in diameter." 02/01/1991 - "In the present study bilateral lesions were analysed by extensive histological examination in the following groups of patients: (1) Forty-six women (median age 44 years) with clinical and mammographical unilateral invasive breast carcinoma, where the contralateral breast was removed at subcutaneous mastectomy (SCM) during the course of breast reconstruction, 24/46 (52%) had bilateral malignant lesions, four invasive carcinomas and 20 in situ carcinomas (two ductal carcinomas in situ /DCIS/, 15 lobular carcinomas in situ (LCIS), three both DCIS and LCIS). " 07/01/1993 - "Subcutaneous mastectomy with axillary dissection was an effective operation for early breast cancer including multicentric lesions and some non-invasive ductal carcinomas from the prognostic and cosmetic standpoints." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Silicones
2.	Cosmetics
3.	baysilon (polydimethylsiloxane)
4.	Hydrogel
5.	Fluorescein (Funduscein)
6.	Steroids
7.	Silicon
8.	Prednisolone (Predate)
9.	Polyvinyls
10.	Polyurethanes (Polyurethane)

Related Therapies and Procedures

1.	Mammaplasty (Breast Reconstruction)
2.	Modified Radical Mastectomy (Mastectomy, Modified)
3.	Prostheses and Implants (Prosthesis)
4.	Mastectomy (Mammectomy)
5.	Simple Mastectomy

Best Treatments:
Research Summary Report
on Breast Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3864 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>